Patient Protection and Affordable Care Act (ACA) impacts the pharma and biotech industries.
Failures get a postmortem. Why not triumphs?
What can be done to restore U.S. competitiveness?
Explore the unique challenges of science-based businesses.
HBS Professor Gary Pisano on U.S. innovation outsourcing and what it means in today's world.
Growth can dull your operational edge. Read how to keep it honed.
Outsourcing has left U.S. industry without the means to invent innovative new products.
Stoke up research and innovation for long-term success.
Reduce R&D costs today while preserving opportunities for growth tomorrow.
Did Christensen warrant both keynote slots at the World Innovation Forum?
Map out your options and your competitors' before making big-ticket investments.
New leaders in innovation will be those who figure out the best way to leverage a network of outsiders.
The numbers are in on the biotech business—and it's not what you'd expect.
Biotech promised to revolutionize pharmaceutical R&D, but it needs an anatomy adjustment.